Iproveratril

Iproveratril Brand names, Iproveratril Analogs

Iproveratril Brand Names Mixture

Tarka (trandolapril + verapamil hydrochloride)

Iproveratril Chemical_Formula

C₂₇H₃₈N₂O₄

Iproveratril RX_link

http://www.rxlist.com/cgi/generic/verapsr.htm

Iproveratril fda sheet

Iproveratril FDA

Iproveratril msds (material safety sheet)

Iproveratril Synthesis Reference

Dengel, U.S. Pat. 3,261,859 (1966)

Iproveratril Molecular Weight

454.602 g/mol

Iproveratril Melting Point

< 25 ^oC

Iproveratril H₂O Solubility

4.47 mg/L

Iproveratril State

Liquid

Iproveratril LogP

5.931

Iproveratril Dosage Forms

Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)

Iproveratril Indication

For the treatment of hypertension and angina.

Iproveratril Pharmacology

Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.

Iproveratril Absorption

90%

Iproveratril side effects and Toxicity

LD₅₀=8 mg/kg (i.v. in mice)

Iproveratril Patient Information

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Iproveratril Organisms Affected

Humans and other mammals